To All
Informative commentary on AMLN yesterday.
1/04/00 - Cruttenden Roth Analyst to Interview On RadioWallStreet Internet Broadcast
PHILADELPHIA, Jan 04, 2000 (BUSINESS WIRE) -- Jan. 4, 2000 - Amgen,
Inc. (NASDAQ: AMGN), Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), and
Immunex rporation (NASDAQ: IMNX) will be discussed by Cruttenden Roth Senior Vice President and Bio-Tech Analyst, Fariba F. Ghodsian, on RadioWallStreet Tuesday, January 4, 2000 at 2:00 PM EST, Investor Broadcast Network announced.
To access this RadioWallStreet broadcast, investors should go to radiowallstreet.com. Listeners should go to the website at least fifteen minutes before these events to register, download, and install any necessary audio software.
For those unable to attend the live broadcast, replays will be available beginning approximately one hour after each event.
There is no charge to access any event. If you are viewing this release after the day of the event, you will find this interview in the "All Recent Shows" section of the website.
Lynn Peters
|
